Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 26, 2026

Annual Results 2025: clear second half improvement, restructuring measures show first results

View original at globenewswire.com
Annual Results 2025: clear second half improvement, restructuring measures show first results Ad hoc announcement pursuant to Article 53 LR 26 February 2026 – 06:30 AM The Feintool Group’s business performance in the 2025 financial year reflects a market environment that remains challenging, with differing dynamics acr…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Around 60% of new orders relate to e-motor core projects in Europe and Asia

    80% confidence
  • Roughly one third of e-lamination stamping volumes are linked to automotive applications and around two thirds to industrial uses

    80% confidence
  • The global automotive market is growing at a low single-digit rate

    80% confidence
  • Global megatrends towards low-carbon energy generation, storage and mobility remain intact and continue to offer attractive growth potential

    80% confidence
  • The full annual earnings contribution from restructuring measures is expected to be realized from the 2026 financial year onwards, with associated annual savings of around CHF 12 million

    80% confidence
  • Restructuring measures have significantly reduced the break-even level

    80% confidence
  • Capital expenditure is expected to shift towards maintenance, efficiency-driven projects as well as selected capacity expansions, especially in North America and Asia, supporting a structurally improved free cash flow profile

    80% confidence
  • Feintool anticipates further improvement in EBIT margins in local currencies for 2026

    80% confidence
  • New sales-relevant, large-volume programs will start up across the group in 2026

    80% confidence
  • Feintool reaffirms its mid-term target of achieving an EBIT margin of more than 6%

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com